MindMate: A Study of a Reminder System for People With Dementia

November 2, 2018 updated by: NHS Greater Glasgow and Clyde

MindMate: A Single Case Experimental Design Study of a Reminder System for People With Mild Dementia

A study to investigate the effectiveness of a reminder tool application at increasing performance on memory tasks in people with mild dementia

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Background

Memory difficulties are a core feature of dementia. These include difficulties remembering to do something at a specific time and place in the future (Prospective Memory). Although a range of electronic prospective memory aids currently exist (e.g. "Neuropage"), the evidence supporting their use among the dementia population remains limited. "Mindmate" is a recently developed mobile application that aims to support individuals with a diagnosis of dementia, improving self-management skills and quality of life.

Aims

This study will explore the effectiveness of "MindMate" reminder alerts delivered to a smart phone or tablet computer as a memory aid for people with a diagnosis of Mild Dementia.

Method

Three participants with a diagnosis of dementia, who are considered to be in the early stages and who report everyday prospective memory difficulties, will be recruited from Older People Community Mental Health teams within Greater Glasgow and Clyde. The participants will own a smart phone or tablet and will be living with a partner or family member who will also participate in the study. During the initial baseline phase, the partner or family member will monitor the number of pre defined tasks the participant remembered and forgot. The partner or family member will record this information on a weekly monitoring form and this phase will last between five to seven weeks. This will be followed by a five-week intervention phase where "MindMate" reminder alerts will be sent to the participant's phone or tablet. Again, tasks that require remembering will be identified prior to the intervention phase, and family members or carers will monitor their success on a form. Results will be analysed using visual inspection and Tau-U analysis.

Applications

This study will provide information on the effectiveness of a form of assistive technology at supporting people with a dementia, which could improve quality of life of those with a diagnosis.

Study Type

Interventional

Enrollment (Actual)

3

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Glasgow, United Kingdom
        • NHS Greater Glasgow and Clyde

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • has a diagnosis of Mild Dementia, according to International Classification of Diseases (ICD) 10 Criteria
  • has received the diagnosis from a psychiatrist
  • owns a smart phone or tablet
  • has a family member/partner/carer who is willing to monitor memory aid use
  • has capacity to consent to being involved in the research
  • is reporting memory difficulties that are affecting them in daily life

Exclusion Criteria:

  • visual or auditory difficulties which cannot be corrected through the use of appropriate aids
  • has a pre-existing neurological or severe psychiatric problem (e.g. bipolar disorder, psychosis)
  • has a diagnosis of dementia that is considered to be in the moderate to severe stages
  • those whose first language is not English
  • those with a diagnosed or suspected developmental learning disability
  • those who are currently using online or electronic memory aids

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 5 week baseline
5 week baseline data collection followed by 6 week MindMate intervention
A dementia-specific mobile reminding application
EXPERIMENTAL: 6 week baseline
6 week baseline data collection followed by 6 week MindMate intervention
A dementia-specific mobile reminding application
EXPERIMENTAL: 7 week baseline
7 week baseline data collection followed by 6 week MindMate intervention
A dementia-specific mobile reminding application

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Memory
Time Frame: 6 weeks
Number of target events the participant remembered to complete
6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Acceptability
Time Frame: Change from baseline to 6 week post-intervention
Unified Theory of Acceptance and Use of Technology (UTAUT) questionnaire
Change from baseline to 6 week post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Jonathan Evans, BSc DClinPsy PhD, University of Glasgow

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 17, 2017

Primary Completion (ACTUAL)

July 31, 2018

Study Completion (ACTUAL)

July 31, 2018

Study Registration Dates

First Submitted

September 19, 2016

First Submitted That Met QC Criteria

September 20, 2016

First Posted (ESTIMATE)

September 21, 2016

Study Record Updates

Last Update Posted (ACTUAL)

November 6, 2018

Last Update Submitted That Met QC Criteria

November 2, 2018

Last Verified

November 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dementia

Clinical Trials on MindMate

Subscribe